Siemens Healthineers AG (0PMJ.L)
EUR 53.27
(0.12%)
EUR 53.27
(0.12%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 4.22 Billion EUR | 11.75% |
| 2023 | 3.77 Billion EUR | -11.26% |
| 2022 | 4.25 Billion EUR | 21.22% |
| 2021 | 3.52 Billion EUR | 25.04% |
| 2020 | 2.84 Billion EUR | -4.26% |
| 2019 | 2.93 Billion EUR | 15.86% |
| 2018 | 2.52 Billion EUR | -12.11% |
| 2017 | 2.8 Billion EUR | 5.8% |
| 2016 | 2.71 Billion EUR | 6.61% |
| 2015 | 2.54 Billion EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 974 Million EUR | -2.66% |
| 2024 Q1 | 941 Million EUR | -21.78% |
| 2024 Q3 | 983 Million EUR | 9.83% |
| 2023 FY | - EUR | -11.26% |
| 2023 Q3 | 913 Million EUR | 15.57% |
| 2023 Q4 | 1.2 Billion EUR | 31.87% |
| 2023 Q1 | 874 Million EUR | -28.83% |
| 2023 Q2 | 790 Million EUR | -9.61% |
| 2022 Q1 | 1 Billion EUR | 10.5% |
| 2022 Q4 | 1.22 Billion EUR | 36.29% |
| 2022 Q3 | 901 Million EUR | -20.48% |
| 2022 Q2 | 1.13 Billion EUR | 13.3% |
| 2022 FY | - EUR | 21.22% |
| 2021 Q1 | 828 Million EUR | 6.02% |
| 2021 FY | - EUR | 25.04% |
| 2021 Q4 | 905 Million EUR | -5.33% |
| 2021 Q3 | 956 Million EUR | 14.08% |
| 2021 Q2 | 838 Million EUR | 1.21% |
| 2020 Q1 | 645 Million EUR | -46.65% |
| 2020 FY | - EUR | -4.26% |
| 2020 Q2 | 788 Million EUR | 22.17% |
| 2020 Q4 | 781 Million EUR | 23.58% |
| 2020 Q3 | 632 Million EUR | -19.8% |
| 2019 Q4 | 1.2 Billion EUR | 85.43% |
| 2019 Q3 | 652 Million EUR | -10.93% |
| 2019 Q2 | 732 Million EUR | 15.64% |
| 2019 Q1 | 633 Million EUR | -36.06% |
| 2019 FY | - EUR | 15.86% |
| 2018 Q4 | 990 Million EUR | 110.64% |
| 2018 FY | - EUR | -12.11% |
| 2018 Q3 | 470 Million EUR | -17.98% |
| 2018 Q2 | 573 Million EUR | -6.83% |
| 2018 Q1 | 615 Million EUR | -45.53% |
| 2017 Q1 | 730 Million EUR | 0.0% |
| 2017 FY | - EUR | 5.8% |
| 2017 Q3 | 519 Million EUR | -19.91% |
| 2017 Q2 | 648 Million EUR | -11.23% |
| 2017 Q4 | 1.12 Billion EUR | 117.53% |
| 2016 FY | - EUR | 6.61% |
| 2015 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Cegedim SA | 95.25 Million EUR | -4335.649% |
| Guerbet SA | 90.09 Million EUR | -4589.546% |
| Nexus AG | 53.43 Million EUR | -7807.395% |
| Bastide Le Confort Médical SA | 110.32 Million EUR | -3729.629% |
| Revenio Group Oyj | 30.09 Million EUR | -13941.21% |
| Drägerwerk AG & Co. KGaA | 318.33 Million EUR | -1227.222% |
| Sartorius Aktiengesellschaft | 811.2 Million EUR | -420.833% |
| LNA Santé SA | 144.63 Million EUR | -2821.146% |
| Medios AG | 52.81 Million EUR | -7899.47% |
| Equasens Société anonyme | 71.29 Million EUR | -5825.749% |
| Stratec SE | 39.82 Million EUR | -10509.98% |